AbbVie (ABBV) Sends A Troubling Message To Gilead Sciences (GILD)

Gilead Sciences, Inc. (NASDAQ: GILD) If you follow biotech stocks, you know the name Gilead Sciences. The bottom line is that this is a massive company that controls both the hepatitis C and HIV treatment spaces. However, they’ve received a troubling message relatively recently… AbbVie Inc (NYSE: ABBV) AbbVie is another pharmaceutical giant. While they’re … Read more

April Earnings To Watch | ABBV | GILD | PFE | MRK

April is more than half way over. However, the most exciting part of the month for many is soon to come! As we move into earnings season, big names in health care are getting set to release their reports. Below are a few earnings reports that I’ll be watching closely and what I expect to … Read more

Gilead Sciences (GILD) Stock Holders…Get Ready For Big Gains!

Gilead Sciences, Inc. (NASDAQ: GILD) If you follow my writing, you know that one of my favorite seasons is upon us once again. It’s earnings report season and GILD will be releasing theirs very soon! When it comes to biotech, there are few stocks that are more interesting to me than Gilead Sciences; and I’m … Read more

Biotech Stock News (OREX) (ABBV) (PCYC) (GILD) (OHRP)

Orexigen Therapeutics (OREX) Shares of Orexigen Therapeutics were up 40% on 3/3/15 when the company announced that early safety data showed that Contrave was not only safe to take but in addition it was able to reduce a patient’s risk of generating cardiovascular health issues such as a heart-attack. Contrave was approved by the FDA … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more